Epidemiology of peripheral vascular disease

Atherosclerosis

Volumn 131, Issue SUPPL., 1997, Pages

  Fowkes, F G R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMORBIDITY; CONFERENCE PAPER; CORONARY ARTERY DISEASE; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; INTERMITTENT CLAUDICATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; STROKE;

EID: 0030835977     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)06122-4     Document Type: Conference Paper

References (16)

1. Fowkes FGR, Housley E, Cawood EHH, Macintyre CCA, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384.
2. Fowkes FGR. Epidemiology of occult atherosclerosis in the lower limbs. In: Salmasi A-M and Nicolaides AN (Eds). Occult Atherosclerotic Disease. Dordrecht: Kluwer Academic, 1991;189.
3. Bainton D, Sweetnam P, Baker I, Elwood P. Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. Br Heart J 1994;72:128.
4. Ogren M, Hedblad B, Isacsson S-O, Janzon L, Junquist G, Lindell S-E. Non-invasively detected carotid stenosis and ischaemic heart disease in men with leg arteriosclerosis. Lancet 1993;342:1138.
5. Leng GC, Lee AJ, Fowkes FGR, Whiteman M, Dunbar J, Housley E, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J 1996;25:1172.
6. Lord JW. Cigarette smoking and peripheral atherosclerotic occlusive disease. J Am Med Assoc 1965;191:249.
7. Fowkes FGR. Epidemiology of atherosclerotic arterial disease in the lower limbs. Eur J Vasc Surg 1988;2:283.
8. Fowkes FGR, Housley E, Riemersma RA, Macintyre CCA, Cawood EHH, Prescott RJ, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared to ischaemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992;135:331.
9. Bulpitt CJ. Blood pressure. In: Fowkes FGR. (Ed) Epidemiology of Peripheral Vascular Disease. London: Springer Verlag, 1991;182.
10. Kannel WB, McGhee DL. Update on some epidemiological features of intermittent claudication: the Framingham Study. J Am Ger Soc 1985;33:13.
11. Leng GC, Fowkes FGR. Lipids: epidemiology. In: Fowkes FGR (Ed). Epidemiology of Peripheral Vascular Disease. London: Springer Verlag, 1991;167.
12. Pomrehn P, Duncan B, Weissfeld L, Wallace RB, Barnes R, Heiss G, et al. The association of dyslipoproteinaemia with symptoms and signs of peripheral arterial disease. The Lipid Research Clinics Prevalence Study. Circulation 1986;73(Suppl.1):1.
13. Schroll M, Munck O. Estimation of peripheral ateriosclerotic disease by ankle blood pressure measurements in a population study of 60 year old men and women. J Chron Dis 1981;34:261.
14. Lowe GDO, Fowkes FGR, Dawes J, Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen and activation of coagulation and leucocytes in peripheral; arterial disease and the normal population in the Edinburgh Artery Study. Circulation 1993;87:1915.
15. Lee AJ, Fowkes FGR, Lowe GDO, Rumley A. Fibrin D-dimer, haemostatic factors and peripheral arterial disease. Thromb Haemost 1995;74:828.
16. Smith FB, Lee AJ, Rumley A, Fowkes FGR, Lowe GDO. Tissue-plasminogen activator, plasminogen activator and risk of peripheral arterial disease. Atherosclerosis 1995;115:35.